维普期刊资源整合服务平台（V6.5）

维普中文期刊产品整合服务

10篇 您的检索式：作者名="Steven Simoens"

选中清除导出查看参考文献查看引证文献引用追踪共1页首页上一页第1页下一页末页 /1 跳转

		题名	作者	年代	出处	被引量
	1	Generic Medicines: Solutions for a Sustainable Drug Market?显示文摘	Pieter Dylst Arnold Vulto Brian Godman Steven Simoens	2013	Applied Health Economics and Health Policy2013，，5：	1
	2	Pricing and reimbursement of orphan drugs:the need for more transparency显示文摘	Steven Simoens	2011	Simoens Orphanet Journal of Rare Diseases2011，6，：	1
	3	The supply of physician services in OECD countries显示文摘	Steven Simoens Jeremy Hurst	2006	DELSA/HEA/WD/ HWP2006，，1：	1
	4	Pricing and reimbursement of orphan drugs: the need for more transparency 显示文摘	Steven Simoens	2011	Orphanet Jour- nal of Rare Diseases2011，，6：	1
	5	Preventing COPD exacerbations with macrolides: a review and budget impact analysis显示文摘	Steven Simoens Gert Laekeman Marc Decramer	2013	Respiratory medicine2013，107，5：	1
	6	Economic effects of clinical pharmacy intervenfions:A literature review显示文摘	Thomas De Rijdt Ludo Willems Steven Simoens	2008	Am J Health-SystPharm2008，65，15：	1
	7	Economic effects of clinical pharmacy interventions: A literature review显示文摘	Thomas De Rijdt Ludo Willems Steven Simoens	2008	American Journal of Health-System Pharmacy2008，，12：	1
	8	Dynamic deployment and quality adaptation for mobile augmented reality applications显示文摘	Tim Verbelen Tim Stevens Pieter Simoens Filip De Turck Bart Dhoedt	2011	The Journal of Systems & Software2011，，11：	1
	9	Pharmaco-economics of community maintenance for opiate dependence:A review of evidence and methodology 显示文摘	Steven S Simoens A Catriona M	2006	Drug and Alcohol Dependence2006，84，1：	1
	10	Greater awareness of biosimilars and shared decision-making among patients attending rheumatology practices in Colorado,United States:Real-world data显示文摘BACKGROUND There is a lack of studies and educational programs focused on biosimilars and shared decision-making among patients diagnosed with various rheumatic diseases.AIM To improve knowledge and awareness of biosimilars and shared decision-making among patients attending rheumatology practices in Colorado as well as to assess a rheumatology patient’s interest in discussing biosimilars as well as shared decision-making with others(e.g.,medical professionals,family members,friends).METHODS Our goal was to work with 80 rheumatology teams in Colorado.We developed and distributed 2000 multi-page brochures to each participating office and later conducted an online anonymous survey.RESULTS There were a total of 49(2.5%)rheumatology patients who responded to our survey.After reading our educational booklet,many survey respondents identified the correct answer in most questions focused on biosimilars or shared decision-making.Our survey results suggest that patients attending rheumatology practices in Colorado are generally not involved in discussions with their providers regarding treatment plans or options.The improvement in scores after reading our educational materials was statistically significant for biosimilars and shared decision-making.CONCLUSION Overall,the level of knowledge and awareness of biosimilars and shared decisionmaking among patients attending rheumatology practices in Colorado was low.More educational programs as well as follow up trainings to measure changes in knowledge and awareness regarding biosimilars and shared decision-making among patients attending rheumatology practices are recommended.	Rovshan Ismailov Steven Simoens Zaytuna Khasanova	2020	World Journal of Rheumatology2020，10，1：	0

返回顶部每页显示：

共1页首页上一页第1页下一页末页 /1 跳转

goolge学术搜索-维普

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1　渝公网安备 50019002500403号　违法和不良信息举报中心

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费